CONSOLIDATED BALANCE SHEETS - USD ($) $ in Thousands	Mar. 31, 2023	Mar. 31, 2022
Assets
Cash and cash equivalents	$ 15,992	$ 14,466
Accounts receivable, net	13,728	11,899
Revenue earned but not billed	1,320	2,421
Inventories, net	18,205	19,832
Prepaid expenses and other current assets	1,116	2,631
Total current assets	50,361	51,249
Property and equipment, net	10,470	11,466
Goodwill	1,484	350
Other intangible assets, net	6,004	2,404
Deferred tax assets	0	17,805
Other long-term assets	3,260	3,543
Total Assets	71,579	86,817
Liabilities and Shareholders’ Equity
Accounts payable	13,405	9,855
Accrued expenses and other	10,552	8,427
Deferred revenue, current	480	76
Current maturities of long-term debt	17	16
Total current liabilities	24,454	18,374
Revolving credit facility	10,000	0
Long-term debt, less current maturities	3	19
Deferred revenue, long-term	489	564
Other long-term liabilities	3,384	2,760
Total liabilities	38,330	21,717
Commitments and contingencies (Note 14)
Shareholders’ equity:
Preferred stock, $0.01 par value: Shares authorized: 30,000,000 shares at March 31, 2023 and 2022; no shares issued and outstanding at March 31, 2023 and 2022	0	0
Common stock, no par value: Shares authorized: 200,000,000 at March 31, 2023 and 2022; shares issued: 41,767,092 and 40,279,050 at March 31, 2023 and 2022; shares outstanding: 32,295,408 and 30,805,300 at March 31, 2023 and 2022	0	0
Additional paid-in capital	160,907	158,419
Treasury stock: 9,471,684 and 9,473,750 common shares at March 31, 2022 and 2021	(36,237)	(36,239)
Retained deficit	(91,421)	(57,080)
Total shareholders’ equity	33,249	65,100
Total liabilities and shareholders’ equity	$ 71,579	$ 86,817